James Peyer, Phd Email & Phone Number

New York, New York, Us

Cambrian is developing new therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.​​Through the Cambrian Engine, we partner with exceptional scientists to bring a new class of medicines to patients in need with the potential to both treat and prevent today’s deadliest diseases. Our engine is built around understanding the deep science of the molecular Drivers of Aging, particularly molecular alterations, cellular dysfunction and tissue degeneration.

New York, New York, Us

Berlin, De

Apollo Ventures is an Early Stage Investment Fund interested in accelerating breakthrough scientific discoveries to the clinic by building life science companies around new therapeutic technologies. Apollo Ventures focuses on assets with the potential to treat, prevent, or even reverse age-related diseases such as Alzheimer's, Heart Disease, Sarcopenia, Frailty, and Cancer, with the ultimate goal of increasing healthy human lifespan.James founded Apollo in 2016 with Nils Regge, Ole Mensching, and Alexandra Bause to establish an evergreen investment structure for making impact in the emerging longevity biotech space. James led Apollo to become one of the world's leading investors in longevity biotech.

Us

Member of the New York Office Pharmaceuticals and Medical Products Practice (PMP) with a focus on biotech venture formation, asset diligence, and commercialization of new therapies.

Doctor Of Philosophy (Phd), Stem Cell Biology

Bachelor Of Arts (B.A.), Biology